Perspectives

Practical thinking on the work that drives patient impact.

Filter

Type

Topics

AI and Drug Discovery: The Virtual Lab's Role in Revolutionizing Biopharma R&D

Blog 2 min

AI Is Not Ready to Be the Decision-Maker — And Pretending Otherwise Is the Real Risk

White Paper 2 min

Decision Latency Is a Growth Strategy Problem: Redesigning Portfolio Governance for Speed and Discipline

White Paper 2 min

Designing High Performing Organizations Through Strategic Workforce Planning (SWP)

White Paper 2 min

Do More of The Work You Love: Maximizing Your Productivity & Finding Your Happiness

White Paper 2 min

Escape Meeting Purgatory with Strategic Business Management

White Paper 2 min

Five Winning Mantras to Optimize CRO Partnerships

White Paper 2 min

From Dealmaking to Strategic Access: The New Partnership Agenda in Life Sciences

White Paper 2 min

Harnessing Structure for Leadership Excellence: A Business Manager's Blueprint

White Paper 2 min

Impact of Gender Diversity on Financial Performance in the Fortune 500

White Paper 2 min

Improving Quality Systems Through Simplifying Procedures and Documentation

White Paper 2 min

Inserting Agile Project Management into the DNA of Biopharma

White Paper 2 min

Integrating Company Cultures in Mergers and Acquisitions

White Paper 2 min

Launch Excellence and Patient Centricity

White Paper 2 min

Portfolio Strategy and Placing Bets in Biopharma

White Paper 2 min

Stop Asking Build vs. Buy — Most Biotechs Don't Have an AI Strategy at All

White Paper 2 min

Strategic Ambition is Not Enough: The Value Realization Imperative for Biopharma

White Paper 2 min

The Calendar is the Real Operating System of Leadership (And It's Failing Us)

White Paper 2 min

The Evolving World of Global Regulatory Affairs: Embracing Artificial Intelligence (AI)

White Paper 2 min

The Evolving World of Global Regulatory Affairs: Navigating Change and Embracing Innovation

White Paper 2 min

The Evolving World of Global Regulatory Affairs: Shaping Regulatory Gold Standards and Processes

White Paper 2 min

The Evolving World of Global Regulatory Affairs: The Impact of New Modalities

White Paper 2 min

The Evolving World of Global Regulatory Affairs: The Interplay between Harmonization, RWE/RWD, and AI

White Paper 2 min

The Portfolio Imperative: Converting AI Investment into Compounding Enterprise Value

White Paper 2 min

The Use of Decentralized Clinical Trials (DCTs)

White Paper 2 min

What the ELEVIDYS FDA Approval Means for Future Gene and Cell Therapy Approvals

White Paper 2 min

Why AI Fails to Scale in Biopharma: 3 Breaking Points for the C-Suite

White Paper 2 min

Custom IT-Focused AI Bootcamp for Mid-Sized Biotech

A four-session, IT-focused AI bootcamp built to prepare an IT department for responsible enterprise-wide AI adoption.

Case Study 2 min

Data Security & End-User Support for AI Tools

Hands-on training covering data-exposure risks, AI-specific permission interactions, user misuse patterns, and IT triage workflows.

Case Study 2 min

Platform Architecture & Comparative Tradeoffs Curriculum

Side-by-side training on how Copilot, Claude, and other enterprise AI platforms handle data, identity, retrieval, file handling, agentic features, and pricing.

Case Study 2 min

AI Use Case Prioritization and Implementation Strategy for Client

Identification and prioritization of high-value AI opportunities across development functions to focus upcoming fiscal year investments and align leadership on an actionable digital roadmap.

Case Study 2 min

Launching an AI Center of Excellence

Development of a client's enterprise Advanced Analytics and AI Center of Excellence to develop and operationalize AI strategy, governance, pilot execution, and talent development.

Case Study 2 min

Organizational Readiness for AI Infusion

Redesign of a Strategy & Operations framework to enable enterprise-level alignment, preparing Regulatory Affairs and Technical Development for AI-driven transformation.

Case Study 2 min

Centralized Clinical Asset Planning

Development of a reporting infrastructure to centralize all functional level planning data for 50+ clinical assets being developed in the pipeline.

Case Study 2 min

Efficient R&D Resource Allocation

Development of a reporting infrastructure to drive transparency and facilitate effective resource allocation of 500+ R&D resources to the asset pipeline.

Case Study 2 min

Quality Analytics Drive Quality Event Resolution

Development of a reporting infrastructure and installed business processes to help a pharmaceutical company resolve a backlog of >150 past due quality events.

Case Study 2 min

New Product Brand Planning

Enhancement of position in the marketplace by leading the formation of a mid-size biopharma company's R&D portfolio strategy for its gene therapy division.

Case Study 2 min

Patient Outflows and Solution Assessment

Identification of patient journey outflows and evaluation of tech solutions to close care gaps for a rare disease treatment.

Case Study 2 min

Gene Therapy Program Search and Evaluation in Select Therapeutic and Disease Areas

Conduction of search and evaluation for >500 gene-therapy programs, identifying high priority assets aligned to client's R&D portfolio strategy.

Case Study 2 min

Pediatric Therapeutics Business Development Assessment

Generation of the opportunity universe and prioritization of therapeutic classes to inform a client's decision to enter a new market while complementing their current portfolio.

Case Study 2 min

Early Commercialization Strategy and Go-to-Market Model Design & Development

Support of commercialization for two gene therapy assets by defining the early commercial strategy and proposing the optimal go-to-market model.

Case Study 2 min

Strategic and Tactical Launch Support

Development of a comprehensive launch playbook and organizational model to support a novel autoimmune therapy for a company's first product, enabling a successful market entry and company exit.

Case Study 2 min

Cell & Gene Therapy Supply Chain Tracker

Specialized vein-to-vein logistics and compliance platform managing chain of custody, chain of command, and cryogenic monitoring for cell and gene therapies.

Case Study 2 min

Custom-Built CTMS-Light

Purpose-built clinical trial management system with custom dashboards and near-all critical capabilities of commercial platforms, integrated with existing systems.

Case Study 2 min

Procurement Contract Intelligence Tool

AI-powered contract review, benchmarking, and vendor management platform that turns weeks of manual legal work into minutes.

Case Study 2 min

Data Quality and Alignment Through Master Data Management

Implementation of a centralized MDM platform to unify portfolio and partner data, improving data quality, downstream reporting, and enterprise alignment.

Case Study 2 min

Harmonized Clinical Planning Data

Establishment of standard data definitions, taxonomies, and meta data across functional planning teams to enable centralized reporting.

Case Study 2 min

Scalable Resource Management

Establishment of data definitions, taxonomies, and meta data across a R&D organization to enable scalable resource planning and analytics.

Case Study 2 min

Submission Acceleration

Acceleration of submissions while embedding long-term efficiency and accountability through a multi-year transformation.

Case Study 2 min

Executive Alignment to Re-Shape Portfolio Priorities

Unification of executive leadership around data-driven decisions that balanced survival with long-term growth.

Case Study 2 min

Building an Agile Launch Execution Team for Mission-Critical Launches

Development of an agile launch execution team that delivered two of the company's most successful launches while setting a benchmark for future execution.

Case Study 2 min

54% Filing Time Acceleration

Halving the market approval filing timeline for a late-stage development organization.

Case Study 2 min

CMC Module 3 Acceleration

Redesign of the E2E Module 3 submission process, achieving a 50-day cycle time reduction.

Case Study 2 min

Reducing Trial Cycle Time by 6+ Months

Successful acceleration of development, reducing trial cycle times by over six months.

Case Study 2 min

Opportunity Assessment and Indication Sequencing Strategy

Development of the commercial potential, indication sequencing strategy, and pricing strategy to maximize the commercial opportunity for a novel rare disease therapy.

Case Study 2 min

R&D Gene Therapy Portfolio Strategy Formation

Enhancement of position in the marketplace by leading the formation of a mid-size biopharma company's R&D portfolio strategy for its gene therapy division.

Case Study 2 min

eQMS Implementation for Rapidly Growing Biopharma

Implementation of a digital QMS that modernized quality operations and unlocked scalable compliance performance.

Case Study 2 min

Global GCP Process & Procedure Realignment

Development of a global GCP QMS that transformed compliance from a burden into a strategic capability

Case Study 2 min

Pre-Commercial Biotech QMS Establishment

Development of a pragmatic, inspection-ready QMS that enabled a client's first successful regulatory interactions.

Case Study 2 min

CRO Sourcing Strategy Realignment and Execution for Global Biopharma

Strategic redesign of CRO partnerships to reduce costs, improve delivery, and enhance quality oversight.

Case Study 2 min

Procurement Organization Redesign for Operational Excellence

Transformation of a fragmented procurement structure into a centralized, data-driven organization to improve efficiency, governance, and cost performance.

Case Study 2 min

Digital QMS Implementation

Evaluation and implementation of a digital QMS system to take a rapidly growing biopharma from a paper-based to a digital system.

Case Study 2 min

Global QMS Alignment

Development of a unified global GMP QMS for life sciences organization preparing for both US and EU product filings.

Case Study 2 min

QMS Controls & Training Optimization for Commercial API Site

Modernization of QMS controls and training to close systemic inspection findings and restore inspection readiness at a commercial API manufacturing site.

Case Study 2 min

Harmonizing a Common Resource Management Process after Several M&A Events

Establishment of a common resource management framework across R&D functions after substantial growth through M&A.

Case Study 2 min

Resource Ramp-Up Model Developed to Meet Surging Growth in Pipeline

Development of a customized, fit-for-purpose resource model to help a company proactively manage the surging demand from its future pipeline.

Case Study 2 min

Transforming Medical Writers to Content Strategists Organization

Redesign of a medical writing organization to enable regulatory content transformation and resolve major issues with role clarity and reactive management.

Case Study 2 min

Interim CFO & FP&A Support for Biotech Start-up

Strategic financial leadership to institutionalize governance, oversee ERP implementation, and support capital raise activities during a critical growth phase.

Case Study 2 min

Interim Chief Commercial Officer for CDMO

Aligning commercial infrastructure and market-entry strategy to maximize enterprise value and competitive positioning.

Case Study 2 min

Interim Head of Quality Assurance for Pre-Commercial Biopharma

Rapid deployment of quality leadership to assess QA strategy and drive the development of a comprehensive Quality Management System.

Case Study 2 min

Multi-site Class-A transformation

Achievement of Class-A status over phased pilots and standardization by driving multi-site operational maturity.

Case Study 2 min

OEE & COGS Pilot for Commercial Biologics Line

Reduction of cost-to-produce and improved throughput by standardizing scheduling, reducing cycle-time variability, and anchoring performance in ERP/BI.

Case Study 2 min

Focused Remediation to Enable Tech Transfer

Stabilization of a product family for tech transfer by closing critical deviations, strengthening release controls, and preparing regulator-defensible evidence.

Case Study 2 min

Full-site quality remediation for multi-product API plant

Execution of a comprehensive remediation program that restored compliant production and institutionalized new quality behaviors.

Case Study 2 min

Global Market Access Strategy

Development of country‑level market access roadmaps using pricing/access analogue assessment for a cardiology rare disease asset.

Case Study 2 min

Value Proposition and Franchise Optimization

Tailoring of a value proposition and access strategy for a new oncology therapy in Newly Diagnosed Multiple Myeloma (NDMM).

Case Study 2 min

Change Management & Communications for R&D Integration

Successful acquisition through leading change management, fostering staff engagement, and addressing training needs.

Case Study 2 min

Integration of Large Pharma Clinical Development & Drug Supply

Guidance of a large pharma merger through establishing integration governance, redesigning clinical supply operations, and validating IT systems.

Case Study 2 min

Post-Merger Integration of Large Pharma & Pre- Commercial Biotech

Seamless integration through a core PMO to ensure on-time integration and maximum value capture.

Case Study 2 min

360 Portfolio Oversight Toolkit and Data Hub

Program planning & analytics using standardized templates and scalable data model to enable real-time, 360 portfolio oversight.

Case Study 2 min

Embedding Portfolio-Level Forecasting Capabilities

Portfolio-level forecasting, valuation, and corporate strategy.

Case Study 2 min

Enterprise Resource Forecasting and Planning

Resource forecasting and planning for a top 10 biopharma to address resource bottlenecks and inform prioritization.

Case Study 2 min

Bundled Filing Strategy to Shorten Multi-Region Review Timelines

Shortening of overall review timelines by consolidating related technical changes into bundled filings for multi-region approval.

Case Study 2 min

Portfolio simplification and lifecycle rules

Reduction of regulatory-impacting technical changes by >20% by aligning lifecycle strategy to capacity and filing policy.

Case Study 2 min

Development & Regulatory

Establishment of a scalable leadership operating model that improved execution, accountability, and organizational culture across 700+ Regulatory staff.

Case Study 2 min

Executive Coaching

Definition of a leadership compass to strengthen communication, influence, and decision-making—enhancing individual growth, team engagement, and organizational impact.

Case Study 2 min

HTA Value & Evidence

Implementation of a unified leadership operating framework to drive accountability, alignment, and execution excellence.

Case Study 2 min

Team Coaching

An immersive one-day workshop to help a Data Science team sharpen strategic thinking and communication skills– driving more effective alignment, decision-making, and outcomes.

Case Study 2 min

CDMO Manufacturing Network Partnerships

Streamlining of a CDMO manufacturing network partnerships for a Top-10 biopharma.

Case Study 2 min

Optimizing Biometry Delivery and Cost via an FSP model

Identification and implementation of an optimal biometry FSP support model for a rapidly growing biopharma company.

Case Study 2 min

Sourcing Strategy Strategic Re-Alignment and Execution Support

Identifying, negotiating and driving operations for $750M+ CRO partnerships for a rapidly growing biopharma.

Case Study 2 min

Cross-functional Technical Product Team & Capacity Plan for Complex ADC

Enablement of on-time global launch for a complex ADC by mobilizing a Technical Product Team and an integrated 12-quarter capacity plan.

Case Study 2 min

Inventory & Dual-Sourcing Redesign for Global Launch Readiness

Reduction of stockout risk and improved launch readiness for a geographically dispersed portfolio by redesigning inventory and dual-sourcing strategies.

Case Study 2 min

Supply Chain and Network Strategy for a Pre- Launch Gene Therapy Company

Development of a flexible 5-year supply strategy that cut capacity costs by 25% while reducing supply risk and supporting commercial and clinical gene therapy demand.

Case Study 2 min

Vendor Governance Redesign for Offshored Regulatory Operations

Case Study 2 min

Technical Change Portfolio Principles & Governance Redesign

Redesign of a global life sciences company's technical change portfolio principles and governance across manufacturing, quality, regulatory, and supply chain.

Case Study 2 min

Sorry!

No items currently match your filtering criteria.

Perspectives

AI Use Case Prioritization and Implementation Strategy for Client

AI and Drug Discovery: The Virtual Lab's Role in Revolutionizing Biopharma R&D

AI Is Not Ready to Be the Decision-Maker — And Pretending Otherwise Is the Real Risk

AI vs Automation in Biopharma: A 5-Point Framework for Biopharma Operations

AI's Impact on Life Science Partnerships: Time, Cost, and Strategic Benefits

Beyond the Shot: Biopharma's Quest for Lasting Drug Delivery

Challenging Times Require a Disciplined Approach to Process Improvement

Concluding Thoughts on the Evolving World of Global Regulatory Affairs

Decision Latency Is a Growth Strategy Problem: Redesigning Portfolio Governance for Speed and Discipline

Designing High Performing Organizations Through Strategic Workforce Planning (SWP)

Do More of The Work You Love: Maximizing Your Productivity & Finding Your Happiness

Escape Meeting Purgatory with Strategic Business Management

Five Winning Mantras to Optimize CRO Partnerships

From Dealmaking to Strategic Access: The New Partnership Agenda in Life Sciences

Harnessing Structure for Leadership Excellence: A Business Manager's Blueprint

Impact of Gender Diversity on Financial Performance in the Fortune 500

Improving Quality Systems Through Simplifying Procedures and Documentation

Inserting Agile Project Management into the DNA of Biopharma

Integrating Company Cultures in Mergers and Acquisitions

Launch Excellence and Patient Centricity

Portfolio Strategy and Placing Bets in Biopharma

Stop Asking Build vs. Buy — Most Biotechs Don't Have an AI Strategy at All

Strategic Ambition is Not Enough: The Value Realization Imperative for Biopharma

The Calendar is the Real Operating System of Leadership (And It's Failing Us)

The Evolving World of Global Regulatory Affairs: Embracing Artificial Intelligence (AI)

The Evolving World of Global Regulatory Affairs: Navigating Change and Embracing Innovation

The Evolving World of Global Regulatory Affairs: Shaping Regulatory Gold Standards and Processes

The Evolving World of Global Regulatory Affairs: The Impact of New Modalities

The Evolving World of Global Regulatory Affairs: The Interplay between Harmonization, RWE/RWD, and AI

The Portfolio Imperative: Converting AI Investment into Compounding Enterprise Value

The Use of Decentralized Clinical Trials (DCTs)

What the ELEVIDYS FDA Approval Means for Future Gene and Cell Therapy Approvals

Why AI Fails to Scale in Biopharma: 3 Breaking Points for the C-Suite

Custom IT-Focused AI Bootcamp for Mid-Sized Biotech

Data Security & End-User Support for AI Tools

Platform Architecture & Comparative Tradeoffs Curriculum

AI Use Case Prioritization and Implementation Strategy for Client

Launching an AI Center of Excellence

Organizational Readiness for AI Infusion

Centralized Clinical Asset Planning

Efficient R&D Resource Allocation

Quality Analytics Drive Quality Event Resolution

New Product Brand Planning

Patient Outflows and Solution Assessment

Gene Therapy Program Search and Evaluation in Select Therapeutic and Disease Areas

Pediatric Therapeutics Business Development Assessment

Early Commercialization Strategy and Go-to-Market Model Design & Development

Strategic and Tactical Launch Support

Cell & Gene Therapy Supply Chain Tracker

Custom-Built CTMS-Light

Procurement Contract Intelligence Tool

Data Quality and Alignment Through Master Data Management

Harmonized Clinical Planning Data

Scalable Resource Management

Submission Acceleration

Executive Alignment to Re-Shape Portfolio Priorities

Building an Agile Launch Execution Team for Mission-Critical Launches

54% Filing Time Acceleration

CMC Module 3 Acceleration

Reducing Trial Cycle Time by 6+ Months

Opportunity Assessment and Indication Sequencing Strategy​

R&D Gene Therapy Portfolio Strategy Formation​

eQMS Implementation for Rapidly Growing Biopharma

Global GCP Process & Procedure Realignment

Pre-Commercial Biotech QMS Establishment

CRO Sourcing Strategy Realignment and Execution for Global Biopharma

Procurement Organization Redesign for Operational Excellence

Digital QMS Implementation

Global QMS Alignment

QMS Controls & Training Optimization for Commercial API Site

Harmonizing a Common Resource Management Process after Several M&A Events

Resource Ramp-Up Model Developed to Meet Surging Growth in Pipeline

Transforming Medical Writers to Content Strategists Organization

Interim CFO & FP&A Support for Biotech Start-up

Interim Chief Commercial Officer for CDMO

Interim Head of Quality Assurance for Pre-Commercial Biopharma

Multi-site Class-A transformation

OEE & COGS Pilot for Commercial Biologics Line

Focused Remediation to Enable Tech Transfer​

Opportunity Assessment and Indication Sequencing Strategy

R&D Gene Therapy Portfolio Strategy Formation

Focused Remediation to Enable Tech Transfer

Integration of Large Pharma Clinical Development & Drug Supply

Post-Merger Integration of Large Pharma & Pre- Commercial Biotech

Portfolio simplification and lifecycle rules

Development & Regulatory

Executive Coaching

HTA Value & Evidence

Cross-functional Technical Product Team & Capacity Plan for Complex ADC